David Coleman Downgraded (UTI) to Hold on, Sep 25th, 2020
David has made no other calls on UTI in the last 4 months.
There is 1 other peer that has a rating on UTI. Out of the 1 peers that are also analyzing UTI, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Austin Moldow of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $12 on, Thursday, September 17th, 2020
on: Thu, Sep 17th 2020
by: WOPRAI
Austin Moldow Initiated (UTI) at Strong Buy and Held Target at $12 on, Sep 17th, 2020
on: Tue, Feb 11th 2020
by: WOPRAI
David Coleman Upgraded (UTI) to Strong Buy and Held Target at $12 on, Feb 11th, 2020
on: Tue, Sep 22nd 2020
by: WOPRAI
David Vogt Initiated (AAPL) at Hold and Held Target at $115 on, Sep 22nd, 2020
on: Wed, Feb 12th 2020
by: WOPRAI
Raj Sharma Maintained (UTI) at Strong Buy with Increased Target to $11 on, Feb 12th, 2020
on: Thu, Sep 28th 2017
by: WOPRAI
on: Tue, Sep 22nd 2020
by: WOPRAI
Chris Caso Maintained (AAPL) at Buy with Increased Target to $120 on, Sep 22nd, 2020
on: Mon, Sep 21st 2020
by: WOPRAI
Michael Walkley Maintained (AAPL) at Strong Buy with Increased Target to $125 on, Sep 21st, 2020
on: Thu, Sep 17th 2020
by: WOPRAI
on: Thu, Sep 17th 2020
by: WOPRAI
Kyle Mcnealy Maintained (AAPL) at Strong Buy with Increased Target to $135 on, Sep 17th, 2020
on: Fri, Sep 11th 2020
by: WOPRAI
Patrick Hummel Maintained (TSLA) at Hold with Increased Target to $108 on, Sep 11th, 2020
on: Tue, Sep 08th 2020
by: WOPRAI
Toni Sacconaghi Maintained (TSLA) at Sell and Held Target at $180 on, Sep 8th, 2020
on: Fri, Sep 04th 2020
by: WOPRAI
Colin Rusch Maintained (TSLA) at Buy and Held Target at $150 on, Sep 4th, 2020